Embedded Files
ACA Biotech’s technology platform centers on computational algorithms designed to analyze large-scale genomic and transcriptomic datasets and identify key contributors that determine the physical states of cancer cells. By identifying these state-determining factors, ACA Biotech aims to develop targeted molecular constructs capable of restoring abnormal cellular states toward normal physiological conditions. This approach represents a novel strategy for cancer treatment that complements existing therapies such as chemotherapy, radiation, and immunotherapy.
Product overview
Product overview
Our product suite focuses on computational biology, powered by two of our algorithms developed. Our previous research has demonstrated a high degree of concordance between the outputs of these two algorithms, allowing them to serve as mutual validation tools. These tools will support researchers in academia and industry by providing deeper insights into cancer state properties and potential therapeutic targets. In subsequent phases, the Company plans to translate these computational discoveries into experimental biological constructs designed to restore abnormal cellular states and ultimately enable new therapeutic approaches.
Our Workflow
Our Workflow
Gene expression profiles from normal and cancer cells are provided to our computational pipeline. Our computational tools compute and output key state contributors that make cancer cells deviate from normal states. alongside a fully customized Cell State Contributor Analysis.
The early-stage product includes a comprehensive, customized interpretation and analysis report of the customs’ omics data.
Our standard deliverables
Our standard deliverables
Product 1: Computational Methods
Product 1: Computational Methods
A suite of computational algorithms designed to identify, model, and characterize cellular states from high‑dimensional biological data. These methods support both discovery research and translational applications.
Product 2: Cell State Contributor Analysis Service
Product 2: Cell State Contributor Analysis Service
A computational service that provides prioritized lists of key molecular contributors driving specific cellular states in individualized patient or experimental samples. This enables researchers to identify actionable targets for downstream validation.
Product 3: State-Correction Plasmids
Product 3: State-Correction Plasmids
Custom-designed plasmids generated based on our computational predictions, intended for laboratory testing and experimental validation of cell‑state modulation hypotheses
Product 4: Validated State-Correction Plasmids
Product 4: Validated State-Correction Plasmids
Plasmids that have undergone functional validation and quality control, designed for potential use in translational or pre‑clinical applications requiring modulation of disease‑relevant cell states.
© 2026 ACA Biotech LLC. All Rights Reserved.
Page updated
Google Sites
Report abuse